Zobrazeno 1 - 9
of 9
pro vyhledávání: '"A W, Castellion"'
Publikováno v:
Annals of periodontology. 2(1)
The Food and Drug Administration (FDA) was the pioneer regulatory agency to set standards for clinical studies aimed at approval of new drugs. For years the FDA's rules represented the most thorough, stringent, and consistent policy. Now most other d
Publikováno v:
Gastroenterology. 69:636-640
Pepto-Bismol liquid (primary active constituent, bismuth subsalicy-late) protected the gastric mucosa of rats against the formation of hemorrhagic lesions or erosions in response to cold + restraint stress, to a combination of aspirin and cold + rest
Publikováno v:
Pharmacological Research Communications. 10:13-20
Summary A series of experiments was conducted to determine the efficacy of bismuth subsalicylate slurry in protecting the rat stomach from hemorrhagic lesion or erosion formation resulting from various noxious stimuli. Bismuth subsalicylate slurry (8
Publikováno v:
The American Journal of Digestive Diseases. 20:955-960
The antidiarrheal effectiveness of bismuth subsalicylate was determined in two species of laboratory animals. Doses of castor oil were, at first, found to accelerate significantly the movement of a charcoal test meal along the small intestine of the
Autor:
A W, Castellion, R W, Fulton
Publikováno v:
Kidney international. Supplement. (9)
Saralasin is a highly soluble and stable AII antagonist with a relatively short half-life; therefore, its effects are rapidly reversible when administered i.v. Acute and subacute studies have shown only transient toxicosis with no significant patholo
Publikováno v:
Gastroenterology. 69(3)
Pepto-Bismol liquid (primary active constituent, bismuth subsalicy-late) protected the gastric mucosa of rats against the formation of hemorrhagic lesions or erosions in response to cold + restraint stress, to a combination of aspirin and cold + rest
Autor:
A W, Castellion
Publikováno v:
Drug information journal. 17(1)
The pharmaceutical industry sponsor bears the ultimate responsibility for the verification of all clinical data submitted to the FDA in support of a New Drug Application (NDA). The author provides an overview of a systematic approach to providing qua
Autor:
E A, Swinyard, A W, Castellion
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 151(3)
Publikováno v:
Experimental neurology. 13(2)
Audiogenic seizures were studied in Frings mice 1 to 364 days of age and in O'Grady mice 1 to 60 days of age. The sequential development of audiogenic seizures was very similar in both strains. Although all animals ultimately developed ability to exh